Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
111 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01088984 | Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia | completed | Phase 1 / Phase 2 | 43 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 12 | May 23, 2016 | clinicaltrials |
| NCT01624493 | BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients | withdrawn | Phase 1 / Phase 2 | 0 | Hoosier Cancer Research NetworkOTHER | 3 | Dec 23, 2015 |
| clinicaltrials |
| NCT00351975 | Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases | completed | Phase 1 | 56 | National Cancer Institute (NCI)NIH | 3 | Dec 23, 2014 | clinicaltrials |
| NCT01631279 | A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors | terminated | Phase 1 / Phase 2 | 33 | Proacta, IncorporatedINDUSTRY | 2 | Jun 16, 2014 | clinicaltrials |
| NCT00004932 | STI571 in Treating Patients With Recurrent Leukemia | completed | Phase 1 | 31 | Children's Oncology GroupNETWORK | 7 | Feb 21, 2014 | clinicaltrials |
| NCT00006024 | Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma | completed | Phase 1 | 32 | Children's Oncology GroupNETWORK | 7 | Feb 13, 2014 | clinicaltrials |
| NCT00616213 | PR104 and G-CSF in Treating Patients With Solid Tumors | completed | Phase 1 | 5 | Proacta, IncorporatedINDUSTRY | 2 | Jun 1, 2011 | clinicaltrials |
| NCT01358227 | A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors | completed | Phase 1 | 26 | Proacta, IncorporatedINDUSTRY | 1 | May 24, 2011 | clinicaltrials |
| NCT00459836 | PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors | completed | Phase 1 | 42 | Proacta, IncorporatedINDUSTRY | 2 | Mar 2, 2011 | clinicaltrials |
| NCT00625768 | Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma | completed | Phase 1 | 13 | Antisoma ResearchINDUSTRY | 2 | Aug 25, 2009 | clinicaltrials |
| NCT00237354 | PV-10 Chemoablation of Recurrent Breast Carcinoma | completed | Phase 1 | 15 | Provectus PharmaceuticalsINDUSTRY | 1 | Oct 24, 2008 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials